[Other] Physiologically Based Pharmacokinetics Modeling in Biopharmaceutics: Case Studies for Establishing the Bioequivalence Safe Space for Innovator and Generic Drugs

 Close Closed
Dhanashri@2023 Post time 7 day(s) ago | Show all posts |Read mode
Reward10points

https://doi.org/10.1007/s11095-022-03319-6
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Senior Member
  • post

  • reply

  • points

    690

Latest Reply

Return to the list